Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment

Author:

Martins Salonee1,Salvi Purva1,Lavuri Sai Tejaswi2,Srivastava Manjita1,Sakthivel Shalini3,Barman Muneesh Kumar4,Chand Kailash5,Singh Meenakshi6,Sonkar Subash C.7ORCID,Bhukya Prudhvilal8ORCID

Affiliation:

1. National Institute of Virology (ICMR), India

2. Chalmeda Anand Rao College of Medical Sciences, KNR University of Health Sciences, India

3. Department of Bio-Medical Science, Bharathidasan University, India

4. Laboratory for HIV Research, National Centre for Cell Sciences, Pune, India

5. National Centre for Cell Sciences, Pune, India

6. Transplant Immunology and Immunogenetics Lab (HLA), ACTREC, Tata Memorial Centre, India

7. Multidisciplinary Research Unit, Department of Biochemistry, New Delhi, India

8. National Institute of Virology (ICMR), Pune, India

Abstract

With the evolution of the tissue system and division of function among differentiated cells/tissues, the property of controlled cell growth also evolved in animals. It is when this very control is lost that cancers develop. The immune system's ability to distinguish between self and non-self is central to impeding cancer progression. However, cancer cells in time can develop multiple ways of escaping immune control. Even today, cancer remains a disease of baffling complexity on account of its diverse origin and pathogenesis. Classical methods like surgery, radiation, and chemotherapy have failed to make the cut as idyllic therapy, especially considering the encumbering side-effects and high failure rate. Alternative therapeutic strategies that exploit the immune system itself have proved promising. One of these is monoclonal antibody therapy. In this chapter, the relationship between the immune system and cancer and various forms of immunotherapy are discussed in detail.

Publisher

IGI Global

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3